Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Gains from Sales and Divestitures (2018 - 2019)

Historic Gains from Sales and Divestitures for Rockwell Medical (RMTI) over the last 2 years, with Q3 2019 value amounting to $96542.0.

  • Rockwell Medical's Gains from Sales and Divestitures changed N/A to $96542.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $96542.0, marking a year-over-year change of. This contributed to the annual value of $98500.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that Rockwell Medical reported Gains from Sales and Divestitures of $96542.0 as of Q3 2019.
  • Rockwell Medical's 5-year Gains from Sales and Divestitures high stood at $98500.0 for Q4 2018, and its period low was $96542.0 during Q3 2019.